Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 11788891)

Published in Int J Oncol on February 01, 2002

Authors

Satoru Kase1, Mitsuhiko Osaki, Hironobu Adachi, Nobuaki Kaibara, Hisao Ito

Author Affiliations

1: First Department of Pathology, Faculty of Medicine, Tottori University, Tottori 683-8503, Japan. kaseron@grape.med.tottori-u.ac.jp

Articles citing this

Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer (2006) 1.25

Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis (2011) 0.96

Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population. PLoS One (2013) 0.96

Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system. World J Gastroenterol (2005) 0.88

The role of CD95 and CD95 ligand in cancer. Cell Death Differ (2015) 0.88

Clinical relevance of Fas expression in oesophageal squamous cell carcinoma. J Clin Pathol (2006) 0.87

Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma. BMC Cancer (2009) 0.85

Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis. Neoplasia (2011) 0.78

Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. Mol Clin Oncol (2014) 0.76

Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues. World J Gastroenterol (2010) 0.76

Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissues. Int J Clin Exp Pathol (2015) 0.76

Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population. Cancer Med (2016) 0.75

Articles by these authors

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther (2009) 2.92

MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther (2011) 1.77

IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells (2008) 1.75

Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther (2009) 1.74

Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol (2008) 1.68

Lymph node metastasis at the splenic hilum in proximal gastric cancer. Am Surg (2004) 1.63

The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle (2007) 1.45

Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys (2009) 1.40

Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res (2004) 1.35

Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer (2002) 1.34

Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr (2005) 1.30

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas. Oral Oncol (2008) 1.29

Treatment and prognosis of squamous cell carcinoma of the external auditory canal and middle ear: a multi-institutional retrospective review of 87 patients. Int J Radiat Oncol Biol Phys (2007) 1.27

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer (2003) 1.23

Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation. AJNR Am J Neuroradiol (2004) 1.19

SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells (2010) 1.19

Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol (2002) 1.19

Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer (2006) 1.17

Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology (2004) 1.16

Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med (2005) 1.14

Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One (2011) 1.13

Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol (2008) 1.12

Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas (2004) 1.11

Mutations of the Corynebacterium glutamicum NCgl1221 gene, encoding a mechanosensitive channel homolog, induce L-glutamic acid production. Appl Environ Microbiol (2007) 1.09

Inter- and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma: an attempt to interpret the variable magnetic resonance findings. J Comput Assist Tomogr (2004) 1.09

Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics (2005) 1.07

Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res (2002) 1.07

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci (2006) 1.07

Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus. Jpn J Clin Oncol (2005) 1.07

Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. Int J Oncol (2013) 1.07

Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J Cancer Res Clin Oncol (2003) 1.06

Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer (2007) 1.05

Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. J Med Virol (2002) 1.05

Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett (2007) 1.05

Prostatic stromal sarcoma: case report and review of the literature. Pathol Int (2003) 1.05

Arpp, a new homolog of carp, is preferentially expressed in type 1 skeletal muscle fibers and is markedly induced by denervation. Lab Invest (2002) 1.04

Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol (2003) 1.04

Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J Oral Pathol Med (2012) 1.04

Tubular-trabecular type Basal cell adenoma of the parotid gland: a patient report. Yonago Acta Med (2010) 1.02

Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histograms. Int J Radiat Oncol Biol Phys (2004) 1.02

Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol (2005) 1.02

Japanese structure survey of radiation oncology in 2005 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys (2008) 1.01

Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Oncology (2006) 1.01

Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication. Lung Cancer (2009) 1.01

Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol Cell Biol (2011) 1.01

Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation. Hepatology (2002) 0.99

Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer (2002) 0.99

Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line. Cancer Chemother Pharmacol (2003) 0.98

SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest. Cell Cycle (2009) 0.97

Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol (2010) 0.97

Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis. Cancer Sci (2005) 0.97

FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics (2005) 0.97

CoCl2-induced HIF-1alpha expression correlates with proliferation and apoptosis in MKN-1 cells: a possible role for the PI3K/Akt pathway. Int J Oncol (2006) 0.97

Immunolocalisation of E-cadherin and beta-catenin in human pterygium. Br J Ophthalmol (2007) 0.96

Effects of single or repeated administrations of methamphetamine on immune response in mice. Exp Anim (2008) 0.95

Epstein-Barr virus-infected malignant T/NK-cell lymphoma in a patient with hypersensitivity to mosquito bites. Int J Surg Pathol (2004) 0.95

MR imaging of salivary duct carcinoma. AJNR Am J Neuroradiol (2005) 0.95

Evaluation of computed tomography as a screening test for death inquest. J Forensic Sci (2010) 0.95

The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis Rheum (2008) 0.95

Pyothorax-associated lymphoma: imaging findings. AJR Am J Roentgenol (2010) 0.95

Oral administration of geranylgeranylacetone improves survival rate in a rat endotoxin shock model: administration timing and heat shock protein 70 induction. Shock (2005) 0.95

Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer. Anticancer Res (2004) 0.94

Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer. Gastric Cancer (1999) 0.93

Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. Anticancer Res (2005) 0.92

Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease. Hepatol Res (2010) 0.92

Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Pathol Int (2007) 0.92

CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma. Oncology (2008) 0.92

Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas. Am J Pathol (2002) 0.92

The reliability and validity of the Japanese version of the Appraisal of Diabetes Scale for type 2 diabetes patients. Diabetes Res Clin Pract (2010) 0.91

ARPP protein is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas. Mod Pathol (2007) 0.91

Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today (2005) 0.91

MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications. Pathobiology (2004) 0.91

Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer. Gastric Cancer (2003) 0.91

Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows Arch (2002) 0.90

Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2010) 0.90